Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sakari Simula

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Physiological Reports|September 15, 2016
Modulation of sphingosine receptors influences circadian pattern of cardiac autonomic regulationSakari Simula, Tomi P Laitinen, Tiina M Laitinen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
Effect of fingolimod on cardiac autonomic regulation in patients with multiple sclerosisSakari Simula, Tomi Laitinen, Tiina M Laitinen, et al.
Clinical Physiology and Functional Imaging|December 11, 2012
Baroreflex sensitivity in asymptomatic coronary atherosclerosisSakari Simula, Tomi Laitinen, Esko Vanninen, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 19, 2013
Effect of middle cerebral artery territory ischemic stroke on QT intervalSakari Simula, Antti T Muuronen, Mikko Taina, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|June 21, 2015
Effects of Three Months Fingolimod Therapy on Heart RateSakari Simula, Tomi Laitinen, Tiina M Laitinen, et al.
Brain and Behavior|February 28, 2018
Cardiac repolarization during fingolimod treatment in patients with relapsing-remitting multiple sclerosisAapo Laiho, Tiina M Laitinen, Päivi Hartikainen, et al.
Multiple Sclerosis and Related Disorders|July 13, 2023
Fatigue and health-related quality of life depend on the disability status and clinical course in RRMSHenrik Ahvenjärvi, Marja Niiranen, Sakari Simula, et al.
Brain and Behavior|June 29, 2022
Grey matter atrophy in patients with benign multiple sclerosisMarja Niiranen, Juha Koikkalainen, Jyrki Lötjönen, et al.
Multiple Sclerosis and Related Disorders|June 24, 2020
Corrigendum to "Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation" [Multiple Sclerosis and Related Disorders 38 (2020) 101498]Tiina Mustonen, Ilkka Rauma, Päivi Hartikainen, et al.
Multiple Sclerosis and Related Disorders|December 22, 2019
Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessationTiina Mustonen, Ilkka Rauma, Päivi Hartikainen, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Physiological Reports|September 15, 2016
Modulation of sphingosine receptors influences circadian pattern of cardiac autonomic regulationSakari Simula, Tomi P Laitinen, Tiina M Laitinen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
Effect of fingolimod on cardiac autonomic regulation in patients with multiple sclerosisSakari Simula, Tomi Laitinen, Tiina M Laitinen, et al.
Clinical Physiology and Functional Imaging|December 11, 2012
Baroreflex sensitivity in asymptomatic coronary atherosclerosisSakari Simula, Tomi Laitinen, Esko Vanninen, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 19, 2013
Effect of middle cerebral artery territory ischemic stroke on QT intervalSakari Simula, Antti T Muuronen, Mikko Taina, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|June 21, 2015
Effects of Three Months Fingolimod Therapy on Heart RateSakari Simula, Tomi Laitinen, Tiina M Laitinen, et al.
Brain and Behavior|February 28, 2018
Cardiac repolarization during fingolimod treatment in patients with relapsing-remitting multiple sclerosisAapo Laiho, Tiina M Laitinen, Päivi Hartikainen, et al.
Multiple Sclerosis and Related Disorders|July 13, 2023
Fatigue and health-related quality of life depend on the disability status and clinical course in RRMSHenrik Ahvenjärvi, Marja Niiranen, Sakari Simula, et al.
Brain and Behavior|June 29, 2022
Grey matter atrophy in patients with benign multiple sclerosisMarja Niiranen, Juha Koikkalainen, Jyrki Lötjönen, et al.
Multiple Sclerosis and Related Disorders|June 24, 2020
Corrigendum to "Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation" [Multiple Sclerosis and Related Disorders 38 (2020) 101498]Tiina Mustonen, Ilkka Rauma, Päivi Hartikainen, et al.
Multiple Sclerosis and Related Disorders|December 22, 2019
Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessationTiina Mustonen, Ilkka Rauma, Päivi Hartikainen, et al.
Pageof 3